Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:FRX CVE:GPH TSE:ITH TSE:VBV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFRXForest Road Acquisition$10.30$9.72▼$18.20$450MN/A2.07 million shs40,482 shsGPHGraphite OneC$0.73-3.9%C$0.84C$0.64▼C$1.14C$117.57M1.380765106,014 shs113,661 shsITHInternational Tower Hill MinesC$2.12-3.2%C$1.67C$0.60▼C$2.29C$440.72M0.91461531,077 shs28,432 shsVBVVBI VaccinesC$0.00C$3.85▼C$7.60C$308.86MN/A3,637 shs1,300 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFRXForest Road Acquisition0.00%0.00%0.00%0.00%0.00%GPHGraphite One-3.95%-3.95%-28.43%-8.75%-7.59%ITHInternational Tower Hill Mines-3.20%-4.50%+9.28%+66.93%+207.25%VBVVBI Vaccines0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFRXForest Road Acquisition$10.30$9.72▼$18.20$450MN/A2.07 million shs40,482 shsGPHGraphite OneC$0.73-3.9%C$0.84C$0.64▼C$1.14C$117.57M1.380765106,014 shs113,661 shsITHInternational Tower Hill MinesC$2.12-3.2%C$1.67C$0.60▼C$2.29C$440.72M0.91461531,077 shs28,432 shsVBVVBI VaccinesC$0.00C$3.85▼C$7.60C$308.86MN/A3,637 shs1,300 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFRXForest Road Acquisition0.00%0.00%0.00%0.00%0.00%GPHGraphite One-3.95%-3.95%-28.43%-8.75%-7.59%ITHInternational Tower Hill Mines-3.20%-4.50%+9.28%+66.93%+207.25%VBVVBI Vaccines0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFRXForest Road Acquisition 0.00N/AN/AN/AGPHGraphite One 0.00N/AN/AN/AITHInternational Tower Hill Mines 0.00N/AN/AN/AVBVVBI Vaccines 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFRXForest Road AcquisitionN/AN/AN/AN/A$0.56 per shareN/AGPHGraphite OneN/AN/AC$0.01 per share94.17C$0.44 per shareN/AITHInternational Tower Hill MinesN/AN/AC$0.09 per share22.50C$0.29 per shareN/AVBVVBI VaccinesC$3.36M0.00N/AN/AC$1.01 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFRXForest Road Acquisition-$7.92MN/A0.00N/AN/AN/AN/AN/AN/AGPHGraphite One-C$4.90M-C$0.06N/A∞N/AN/A-10.96%-6.61%N/AITHInternational Tower Hill Mines-C$2.36M-C$0.02N/A∞N/AN/A-5.82%-3.65%N/AVBVVBI VaccinesN/A-C$0.97N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFRXForest Road AcquisitionN/AN/AN/AN/AN/AGPHGraphite OneN/AN/AN/AN/AN/AITHInternational Tower Hill MinesN/AN/AN/AN/AN/AVBVVBI VaccinesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFRXForest Road AcquisitionN/A0.370.37GPHGraphite One0.021.090.33ITHInternational Tower Hill MinesN/A10.3730.48VBVVBI Vaccines14.292.642.54Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFRXForest Road AcquisitionN/AGPHGraphite One0.21%ITHInternational Tower Hill Mines6.08%VBVVBI VaccinesN/AInsider OwnershipCompanyInsider OwnershipFRXForest Road AcquisitionN/AGPHGraphite One28.81%ITHInternational Tower Hill Mines0.51%VBVVBI VaccinesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFRXForest Road AcquisitionN/A37.50 millionN/ANot OptionableGPHGraphite One20161.05 millionN/ANot OptionableITHInternational Tower Hill Mines220207.89 millionN/ANot OptionableVBVVBI Vaccines2264.08 millionN/ANot OptionableGPH, ITH, FRX, and VBV HeadlinesRecent News About These CompaniesDecades of research push cytomegalovirus vaccine closer to realityJanuary 7, 2025 | msn.comFive Covid-19 vaccine false theories - debunkedOctober 26, 2024 | bbc.co.ukVBIVQ VBI Vaccines Inc.August 15, 2024 | seekingalpha.comVBI Vaccines Inc. (Nasdaq: VBIV) Rises from the Ashes and is NASDAQ Top Percentage GainerAugust 6, 2024 | investorideas.comIVBI Vaccines Starts Restructuring Procedure in CanadaJuly 30, 2024 | marketwatch.comVBI Vaccines secures court protection as it restructures, seeks buyer(s)July 30, 2024 | fiercebiotech.comFVBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023April 16, 2024 | msn.comVBI Vaccines sells hepatitis B vaccine candidate, manufacturing digs to partner Brii Biosciences for up to $33 millionFebruary 14, 2024 | fiercepharma.comFThe Truth About VaccinesJanuary 6, 2024 | webmd.comWVBI Vaccines Inc VBIVOctober 31, 2023 | morningstar.comMAccess to new Covid-19 vaccines delayed for Vermonters on MedicaidSeptember 27, 2023 | vtdigger.orgVNo, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact checkSeptember 26, 2023 | usatoday.comAvailability of new 2023–2024 COVID-19 vaccine in VirginiaSeptember 26, 2023 | newsleader.comNThe Consumer’s Guide to RSV Vaccines for Older AdultsSeptember 24, 2023 | everydayhealth.comEUpdated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit mostSeptember 23, 2023 | usatoday.comIs It Safe to Get Multiple Vaccines at the Same Time?September 22, 2023 | everydayhealth.comEThe real data behind the new COVID vaccines the White House is pushingSeptember 21, 2023 | nypost.comNNew COVID vaccines will be available in RI. Here's how to get one.September 20, 2023 | providencejournal.comPCOVID vaccine pill that kills virus before it infects the body could be comingSeptember 15, 2023 | nypost.comNInterim results show Brii’s therapeutic HBV vaccine induces immune responseSeptember 8, 2023 | bioworld.comBNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025Broadcom Named in Apple’s $100B U.S. Investment PlanBy Leo Miller | August 22, 20254 Stocks That May Get a Big Earnings Bump This WeekBy Nathan Reiff | August 11, 2025GPH, ITH, FRX, and VBV Company DescriptionsForest Road Acquisition NYSE:FRXForest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.Graphite One CVE:GPHC$0.73 -0.03 (-3.95%) As of 09/9/2025 03:49 PM EasternGraphite One Inc. operates as mineral exploration company in the United States. The company holds interest in the Graphite Creek property that consists of 135 mining claims located on the Seward Peninsula, Alaska. The company was formerly known as Graphite One Resources Inc. and changed its name to Graphite One Inc. in February 2019. Graphite One Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.International Tower Hill Mines TSE:ITHC$2.12 -0.07 (-3.20%) As of 09/9/2025 04:00 PM EasternInternational Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an advanced stage exploration project namely the Livengood Gold Project. It is located approximately 70 miles northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska mental health trust, a number of smaller private mineral leases, Alaska state mining claims purchased or located by the company and patented ground held by the company.VBI Vaccines TSE:VBVVBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing The Quiet Before the Catalyst: Vertical Aerospace's Next Move Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
